european network for adrenal tumors


4th International Symposium on Adrenal Cancer

  • 22 Feb 2013
  • 23 Feb 2013
  • L’Ecole du Val-de-Grâce, Paris

The Fourth International Symposium on Adrenal Cancer will take place in Paris, February 22-23, 2013.

Visit for further information.

This major meeting will be held under the auspices of ENSAT and with the support of ESF, the French network COMETE, and INCa in the frame of the “rare cancers” program.

The Scientific Committee has developed its program, that will cover all usual aspects of Adrenal Cancer, from the most basic studies on adrenocortical development, to tumor pathogenesis, prognostic factors, molecular markers and genetic approaches, epidemiology, diagnosis, and locoregional as well as systemic medical treatments… presented – and discussed – by the world leaders in the field.

Sufficient time should be allocated for discussion, debates, and round tables.

We anticipate also giving time for oral presentations from selected abstracts of young investigators.

In the small world of ACC specialists, savour of such meetings comes from science… helped by friendship and conviviality!

L’Ecole du Val-de-Grâce, with its Chapel, its Cloister, and its Museum, offers us a prestigious and convenient venue, in the heart of Paris.

Retrospect to the 15th ENSAT meeting in Birmingham Nov 2016

The 15th ENS@T scientific meeting was held at the University of Birmingham and chaired by Wiebke Arlt.
Attendees came from 22 countries to participate in the two day conference, which began on  the Friday at the Everyman Cinema, Mailbox, where there was a packed programme of oral presentations.  Delegates enjoyed networking in the evening  at the Festive Awards Dinner in the Banqueting Suite, Council House, Birmingham.
Day 2 was held at the Medical School, University of Birmingham and consisted of working groups, oral communications and guided poster sessions.  There was also  a parallel patient strand programme in collaboration with ACC Support UK. Patients attending this meeting were given the opportunity to join the conference for some of the sessions.
The meeting is entirely submission-driven and science from the whole of Europe and beyond was presented, focussing on the four different entities, non-aldosterone producing adrenocortical adenoma (NAPACA), adrenocortical carcinoma (ACC), phaeochromocytoma (PHAEO) and primary aldosteronism (APA).
In addition to ENSAT, the conference was supported by the European Society of Endocrinology, HRA Pharma, Millendo Therapeutics and Alta Bioscience.


  © ENS@T - European Network for the Study of Adrenal Tumors 2002 - 2012
Powered by Wild Apricot Membership Software